Marketmind: Mind the gap
- ByReuters-
A look at the day ahead in European and global markets from Anshuman Daga An impressive 6% rally in global stocks this month, the first gain in January after three years, has got...
Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| KASE | USD | Delayed | ||
| Colombia | COP | Delayed | ||
| Lima | USD | Delayed |
A look at the day ahead in European and global markets from Anshuman Daga An impressive 6% rally in global stocks this month, the first gain in January after three years, has got...
By Stephen Culp (Reuters) - A look at the day ahead in markets from Stephen Culp, New York stock market reporter. Wall Street's downbeat start to an action-packed week has set a...
By Liz Moyer Investing.com -- Stocks were falling on Monday as investors prepared for the Federal Reserve's next decision on interest rates on Wednesday plus a slew of earnings...
Fed rate decision, Mega-cap tech earnings, U.S. jobs report in focus. Caterpillar shares are a buy amid strong profit and sales growth. Peloton stock set to underperform amid...
Global drug spending is set to reach $1.9 trillion by 2027. Pfizer remains well-positioned to capture much of this. A price-to-earnings ratio of just 8.7 suggests the stock is...
Drugmaker Merck's (NYSE:MRK) stock has outperformed its competitors year to date (ytd), rising 30.6%. Pfizer (NYSE:PFE), which I am bearish on, is down 16.9% so far this year. The...
Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.
| Average | 54.30 (+24.68% Upside) |
| High | 75.00 |
| Low | 44.00 |
| Price | 43.55 |
| No. of Analysts | 20 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Neutral | Strong Sell | Neutral |
| Technical Indicators | Strong Buy | Buy | Sell | Strong Sell | Strong Sell |
| Summary | Strong Buy | Buy | Neutral | Strong Sell | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 143.00 | 145.55 | 142.85 | -2.93 | -2.01% | 62.93M | NASDAQ | |||
| 12.89 | 13.20 | 12.86 | -0.38 | -2.86% | 64.35M | NYSE | |||
| 100.55 | 101.74 | 99.01 | -1.69 | -1.65% | 68.33M | NASDAQ | |||
| 191.62 | 201.40 | 191.50 | -12.03 | -5.91% | 48.63M | NASDAQ | |||
| 96.94 | 98.29 | 96.39 | -2.43 | -2.45% | 26.96M | NASDAQ | |||
| 113.56 | 115.49 | 113.15 | -2.05 | -1.77% | 18.50M | NYSE | |||
| 147.06 | 151.12 | 146.95 | -4.68 | -3.08% | 27.65M | NASDAQ | |||
| 97.95 | 99.41 | 97.52 | -2.76 | -2.74% | 23.81M | NASDAQ | |||
| 242.71 | 245.60 | 242.20 | -5.45 | -2.20% | 25.68M | NASDAQ | |||
| 131.63 | 132.40 | 130.15 | -1.77 | -1.33% | 9.37M | NASDAQ | |||
| 108.40 | 108.87 | 107.42 | -0.62 | -0.57% | 6.88M | NASDAQ | |||
| 27.95 | 28.51 | 27.67 | -0.21 | -0.75% | 54.80M | NASDAQ | |||
| 0.118 | 0.13 | 0.11 | +0.001 | +0.86% | 1.75M | OTC Markets | |||
| 11.70 | 12.31 | 11.63 | -0.46 | -3.78% | 8.82M | NYSE | |||
| 353.11 | 360.95 | 352.86 | -7.66 | -2.12% | 5.05M | NASDAQ |